Skip to main content
Clinical Trials/ISRCTN55593137
ISRCTN55593137
Completed
未知

A randomised trial of radiotherapy alone versus three cycles of cyclophosphamide, doxorubicin, vincristine and prednisolone (CHOP) chemotherapy plus radiotherapy versus six cycles of CHOP chemotherapy plus radiotherapy for early stage aggressive non-Hodgkin's lymphoma

Cancer Research UK (CRUK) (UK)0 sites0 target enrollmentJuly 1, 2001

Overview

Phase
未知
Intervention
Not specified
Conditions
on-Hodgkin's lymphoma
Sponsor
Cancer Research UK (CRUK) (UK)
Status
Completed
Last Updated
6 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
July 1, 2001
End Date
October 31, 1996
Last Updated
6 years ago
Study Type
Interventional

Investigators

Sponsor
Cancer Research UK (CRUK) (UK)

Eligibility Criteria

Inclusion Criteria

  • 1\. Biopsy\-proven non\-Hodgkin's lymphoma of any of the following histologies: International Working Formulation groups F, G and H; Kiel Classification: centroblastic B\-cell, pleomorphic medium and large T\-cell, immunoblastic, large cell anaplastic and high grade unclassified; Revised European\-American Classification of Lymphoid Neoplasms (REAL Classification): Diffuse large B\-cell, anaplastic large cell, high\-grade B\-cell or Mucosa\-associated lymphoid tissue (MALT) type, and peripheral T\-cell
  • 2\. WHO performance status 0, 1, 2
  • 3\. Aged greater than 15 years
  • 4\. No previous chemotherapy or radiotherapy 5\. Normal lactic dehydrogenase (LDH)
  • 6\. Stage I, IE, II, IIE, except bulky abdominal presentation
  • 7\. No B symptoms
  • 8\. No previous malignancy, except basal cell carcinoma of the skin or cervical carcinoma stage I
  • 9\. No evidence of Human Immunodeficiency Virus (HIV) positively
  • 10\. No contraindications to protocol treatments

Exclusion Criteria

  • Patients with testicular, brain, gastrointestinal or skin primaries are excluded

Outcomes

Primary Outcomes

Not specified

Similar Trials